MiNK Therapeutics, Inc.
INKT· Nasdaq
INKTMiNK Therapeutics, Inc.
Filed Mar 18, 2025 · 10-K · 77 days after period end · 0000950170-25-041379
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$2.46M | -$5.46M | -$7.77M | -$5.76M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MiNK Therapeutics, Inc. · CIK 1840229 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 18, 2025 · 77 d after period end
